{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:30:13Z","timestamp":1790641813770,"version":"4.1.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T00:00:00Z","timestamp":1672099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T00:00:00Z","timestamp":1672099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Patient-reported interstitial lung disease (ILD) questionnaires are commonly used for the evaluation of ILD patients. However, research to test their performance is scarce.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This study aimed to assess the performance of the Chest Questionnaire in consecutive ILD patients presenting to a tertiary ILD center. The results of Chest Questionnaires routinely filled by patients were analyzed together with clinical and demographic data retrieved from the patients\u2019 medical records. The ability of each questionnaire item to detect positive findings, such as environmental and occupational exposures, was examined relative to any additional findings detected by physician-acquired history. History was obtained by an experienced ILD pulmonologist who had access to the results of the questionnaire during the clinic visit.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The final cohort for analysis included 62 patients. Shortness of breath frequency and duration were the questionnaire items with the lowest probability of being filled out by patients. The questionnaire performed well in identifying 96.2% of patients with a positive family history and 90.9% of patients with occupational exposures. However, exposures to mold or birds were frequently missed, self-reported by only 53.1% of exposed patients. Questionnaire\u2019s performance was also lower for other exposures associated with ILD (48.3%). An ILD-related exposure was less likely to be identified by the questionnaire in males (<jats:italic>p<\/jats:italic>\u2009=\u20090.03), while age had no such effect.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The Chest Questionnaire performed well in several domains, while failing to detect some relevant exposures. Therefore, its use should be accompanied by careful history taking by the physician.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12890-022-02294-3","type":"journal-article","created":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T14:04:43Z","timestamp":1672149883000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Importance of physician history taking in complementing patient-reported interstitial lung disease questionnaire"],"prefix":"10.1186","volume":"22","author":[{"given":"Tal Moshe","family":"Perluk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inbal","family":"Friedman Regev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ophir","family":"Freund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eyal","family":"Kleinhendler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzlil","family":"Hershko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharona","family":"Ben-Ami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Bar-Shai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avraham","family":"Unterman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,27]]},"reference":[{"issue":"5","key":"2294_CR1","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","volume":"198","author":"G Raghu","year":"2018","unstructured":"Raghu G, Remy-Jardin M, Myers JL, Richeldi L, Ryerson CJ, Lederer DJ, et al. Diagnosis of idiopathic pulmonary fibrosis. An Official ATS\/ERS\/JRS\/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2018;198(5):e44\u201368.","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"2294_CR2","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1164\/rccm.201702-0400PP","volume":"196","author":"CJ Ryerson","year":"2017","unstructured":"Ryerson CJ, Corte TJ, Lee JS, Richeldi L, Walsh SLF, Myers JL, et al. A standardized diagnostic ontology for fibrotic interstitial lung disease. An International Working Group Perspective. Am J Respir Crit Care Med. 2017;196(10):1249\u201354.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"2294_CR3","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1378\/chest.12-2685","volume":"144","author":"ER Fernandez Perez","year":"2013","unstructured":"Fernandez Perez ER, Swigris JJ, Forssen AV, Tourin O, Solomon JJ, Huie TJ, et al. Identifying an inciting antigen is associated with improved survival in patients with chronic hypersensitivity pneumonitis. Chest. 2013;144(5):1644\u201351.","journal-title":"Chest"},{"issue":"3","key":"2294_CR4","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1164\/rccm.202005-2032ST","volume":"202","author":"G Raghu","year":"2020","unstructured":"Raghu G, Remy-Jardin M, Ryerson CJ, Myers JL, Kreuter M, Vasakova M, et al. Diagnosis of hypersensitivity pneumonitis in adults. An Official ATS\/JRS\/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2020;202(3):e36\u201369.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"2294_CR5","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1159\/000504677","volume":"99","author":"M Polke","year":"2020","unstructured":"Polke M, Kirsten D, Teucher B, Kahn N, Geissler K, Costabel U, et al. A comparison of existing questionnaires for identifying the causes of interstitial and rare Lung Diseases. Respiration. 2020;99(2):119\u201324.","journal-title":"Respiration"},{"issue":"2","key":"2294_CR6","doi-asserted-by":"publisher","first-page":"e97","DOI":"10.1016\/j.chest.2021.03.066","volume":"160","author":"ER Fernandez Perez","year":"2021","unstructured":"Fernandez Perez ER, Travis WD, Lynch DA, Brown KK, Johannson KA, Selman M, et al. Diagnosis and evaluation of hypersensitivity pneumonitis: CHEST Guideline and Expert Panel Report. Chest. 2021;160(2):e97\u2013156.","journal-title":"Chest"},{"key":"2294_CR7","unstructured":"CHEST Interstitial and Diffuse Lung Disease Patient Questionnaire. https:\/\/foundation.chestnet.org\/wp-content\/uploads\/2020\/04\/Interstitial-Diffuse-Lung-Disease-Patient-Questionnaire.pdf. Accessed 2 Feb 2022."},{"issue":"5","key":"2294_CR8","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1513\/AnnalsATS.202008-1002OC","volume":"18","author":"KJ Myall","year":"2021","unstructured":"Myall KJ, Mukherjee B, Castanheira AM, Lam JL, Benedetti G, Mak SM, et al. Persistent Post-COVID-19 interstitial lung disease. An observational study of Corticosteroid Treatment. Ann Am Thorac Soc. 2021;18(5):799\u2013806.","journal-title":"Ann Am Thorac Soc"},{"key":"2294_CR9","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1186\/s12889-016-3352-y","volume":"16","author":"T Boerma","year":"2016","unstructured":"Boerma T, Hosseinpoor AR, Verdes E, Chatterji S. A global assessment of the gender gap in self-reported health with survey data from 59 countries. BMC Public Health. 2016;16:675.","journal-title":"BMC Public Health"},{"issue":"1","key":"2294_CR10","doi-asserted-by":"publisher","first-page":"4318","DOI":"10.1038\/s41598-021-81591-z","volume":"11","author":"Y Park","year":"2021","unstructured":"Park Y, Ahn C, Kim TH. Occupational and environmental risk factors of idiopathic pulmonary fibrosis: a systematic review and meta-analyses. Sci Rep. 2021;11(1):4318.","journal-title":"Sci Rep"},{"issue":"124","key":"2294_CR11","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1183\/09059180.00005111","volume":"21","author":"D Heederik","year":"2012","unstructured":"Heederik D, Henneberger PK, Redlich CA. Asthma ERSTFotMoW-r. primary prevention: exposure reduction, skin exposure and respiratory protection. Eur Respir Rev. 2012;21(124):112\u201324.","journal-title":"Eur Respir Rev"},{"issue":"10","key":"2294_CR12","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1136\/thoraxjnl-2020-215567","volume":"75","author":"CT Lee","year":"2020","unstructured":"Lee CT, Johannson KA. Occupational exposures and IPF: when the dust unsettles. Thorax. 2020;75(10):828\u20139.","journal-title":"Thorax"},{"issue":"5","key":"2294_CR13","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1111\/j.1475-6773.2006.00689.x","volume":"42","author":"M Tai-Seale","year":"2007","unstructured":"Tai-Seale M, McGuire TG, Zhang W. Time allocation in primary care office visits. Health Serv Res. 2007;42(5):1871\u201394.","journal-title":"Health Serv Res"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-022-02294-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-022-02294-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-022-02294-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T14:05:05Z","timestamp":1672149905000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-022-02294-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,27]]},"references-count":13,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2294"],"URL":"https:\/\/doi.org\/10.1186\/s12890-022-02294-3","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,27]]},"assertion":[{"value":"24 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved and reviewed by the Tel Aviv Sourasky Medical Center (TASMC) ethics committee (approval number 0287-21) and was conducted in accordance with the declaration of Helsinki. This retrospective study did not require individual patient consent as indicated by the TASMC ethics committee approval referenced above.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"A.U. reports receiving research funding from Boehringer Ingelheim and the Pulmonary Fibrosis Foundation, personal consulting fees from Boehringer Ingelheim, RemedyCell, Augmanity Nano, and 1E Therapeutics in the last 36 months, and equity in RemedyCell, all outside the submitted work. All other authors report no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"489"}}